gonadotropin-releasing hormone agonist + polyethylene glycol + Rh760

This product is a **combination formulation** comprised of a gonadotropin-releasing hormone agonist (a class of peptide hormone drugs that target the gonadotropin-releasing hormone receptor to modulate reproductive hormone secretion), polyethylene glycol (an inert polymer often used to improve pharmacokinetics or solubility), and Rh760 (a near-infrared fluorescent dye, specifically in the context of FSH-Rh760, for imaging and photothermal therapy in oncology)[1]. While the specific formulation requested (gonadotropin-releasing hormone agonist + polyethylene glycol + Rh760) is not directly described in clinical literature, compounds containing Rh760 are used as targeted imaging agents, leveraging peptide conjugates (e.g. FSH peptide–Rh760) for **tumor-specific imaging and photothermal therapy**, particularly in ovarian cancer.